- CORRESPONDENCE
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Medicine 30, 1807-1808 (2024)
doi: https://doi.org/10.1038/d41591-024-00028-y
Acknowledgements
D.S.I., J.A.B. and J.J.J. are funded by the Bill & Melinda Gates Foundation (INV-0022022) and the National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH) (R01AI156267 to D.S.I., J.A.B. and J.J.J., and K24AI134990 to J.J.J.). D.A.F. is funded in part by the NIH NIAID (R01 AI109023 and R01 AI124678). J.R. is funded in part by the Bill & Melinda Gates Foundation (INV-024346). M.D.C. and P.J.R. are funded by the NIH NIAID (R01AI173557, R01AI075045 and U19AI089674) and by the Bill & Melinda Gates Foundation (INV-035751). D.M. is funded by the Institut Pasteur, Paris; the French Government (Agence Nationale de la Recherche); the Laboratoire d’Excellence (LabEx) “French Parasitology Alliance for Health Care” (ANR-11–15 LABX-0024-PARAFRAP); and the University of Strasbourg. A.A.D. is funded by the Bill & Melinda Gates Foundation (INV-023065 and INV-037659), by an EDCTP2 (European & Developing Countries Clinical Trials Partnership) program supported by the European Union (grant number RIA2017T-2018 WANECAM-2) and by the Science for Africa Foundation with support from Wellcome and the Foreign, Commonwealth and Development Office (grant number Del-22-013).
Competing interests
The authors declare no competing interests.
References
World Health Organization. https://www.who.int/publications/i/item/9789240060265 (18 November 2022).
Rosenthal. P. J. et al. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(24)00141-5 (2024).
Imwong, M. et al. Lancet Infect. Dis. 17, 491–497 (2017).
Dhorda, M. et al. Curr. Opin. Infect. Dis. 34, 432–439 (2021).
Rosenthal, P. J. et al. Nat. Rev. Microbiol. https://doi.org/10.1038/s41579-024-01008-2 (2024).
Juliano, J. J. et al. Preprint at medRxiv https://doi.org/10.1101/2023.11.07.23298207 (2023).
Emiru, T. et al. Nat. Med. 29, 3203–3211 (2023).
Adam M. et al. Trop. Med. Int. Health 28, 817–829 (2023).
Stone W. et al. Lancet Microbe 3, 41–51 (2022).
Tumwebaze, P. K. et al. Nat. Commun. 13, 6353 (2022).